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Background and aims: The histopathologic features of rectal neuroendocrine tumors
(NETs), including size, lymphovascular invasion, invasion of proper muscle, and mitotic
rate, have a limited role to play in determining a treatment plan preoperatively. We aimed
to investigate the morphologic parameters associated with metastasis, and to evaluate
their predictive value.
Methods: Between January 2000 and May 2011, the medical records and endoscopic
ﬁndings of 468 patients presenting with rectal NETs at the Samsung Medical Center were
analyzed retrospectively. All tumors were classiﬁed according to size and endoscopic
features such as color, shape, contour, and surface change.
Results: Twenty-one of the 468 patients (4.5%) with rectal NETs had lymph node (LN)
metastasis and 11 patients (2.4%) had distant metastasis. Risk factors for metastasis
included tumor size (Z10 mm in diameter), hyperemic change, polypoid lesions,
irregular contours, and surface ulceration (p=0.000). Independent risk factors that were
predictive of metastasis on multivariate analysis included tumor size (Z10 mm in
diameter), hyperemic change, and surface ulceration. As the number of independent
risk factors for metastasis increased, the risk of metastasis rose.
Conclusions: Endoscopic features such as hyperemic change, polypoid lesions, irregular
contours, and surface ulcers with tumor size Z10 mm in diameter are associated with
metastasis in rectal NETs. In particular, atypical endoscopic features including hyperemiched by Elsevier GmbH.
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1. Background Rectal neuroendocrine tumors (NETs) comprise
12.6% of all NETs [1]. A recent epidemiologic study
showed that the incidence of rectal NETs has
increased about tenfold over the last 35 years,
and nowadays 50% or more rectal NETs are diag-
nosed as “incidentally” identiﬁed lesions due to
the rapid development of screening sigmoidoscopy
and colonoscopy [2,3]. While the prognosis of patients with metastatic
rectal NETs is no better than that of patients with
metastatic rectal adenocarcinoma, rectal NETs
without metastasis generally have an excellent
ﬁve-year survival rate of 98.9–100% [3–5]. Small
rectal NETs without inﬁltration to the proper
muscle layer or lymph node (LN) metastasis can
be treated effectively and safely through endo-
scopic resection. Hence, when deciding on the
management of rectal NETs, the disease stage
should be taken into consideration [3]. Previous studies have reported several parameters
that can be used to predict the metastatic spread
of rectal NETs, including tumor size, histologic
differentiation, muscular invasion, and lymphovas-
cular invasion [6–9]. However, these parameters
cannot play a role in determining strategies for
treating rectal NETs preoperatively. Tumor size has long been regarded as a reliable
and easily obtained parameter [3,9]. However,
several studies have reported that rectal NETs
smaller than 10 mm have metastasis ranging from
1.7% to 9.7%, illustrating that the risk of metas-
tasis is not governed by primary tumor size alone
[5,7,10–12].
2. Aims of the study To investigate the morphologic parameters asso-
ciated with metastasis in patients with rectal NETs. To assess the risk of metastasis according to
the morphologic parameters that assist indetermining treatment plans for rectal NETs
preoperatively.
3. Study design Between January 2000 and May 2011, the medical
records and endoscopic ﬁndings of 468 patients
presenting with rectal NETs at Samsung Medical
Center were analyzed retrospectively. Speciﬁc data
extracted from the medical records included
patients' age and sex, tumor size, tumor site,
method of resection, and the presence of LN or
distant metastasis. Diagnosis of NETs was conﬁrmed by pathology.
Tumor size was measured using open biopsy
forceps (8 mm in width, FB-24Q-1; Olympus,
Tokyo, Japan) during endoscopy. LN or distant
metastasis was diagnosed based on the results of
a biopsy or surgical resection, or radiologic
ﬁndings consistent with metastasis. All endoscopic features were reviewed by the
authors using photographs of each tumor. All
tumors were classiﬁed according to size and endo-
scopic features such as color, shape, contour, and
surface change.
4. Materials Colonoscope: CF-Q260AI, Olympus Corporation,
Tokyo, Japan. Single band ligator: Stiegmann-goff Clearvue
Endoscopic Ligator, ConMed, New York, USA.
Knives.
 Needle knife: KD-10Q-1, Olympus Corporation,
Tokyo, Japan.
 Hook knife: KD-620LR, Olympus Corporation,
Tokyo, Japan.
 Flex knife: KD-630L, Olympus Corporation, Tokyo,
Japan
Electrosurgical unit: ERBE VIO 300 D, ERBE Elek-
tromedizin GmbH, Tubingen, Germany.5. Endoscopic procedure A total of 369 patients were treated with endoscopic
resection (ER) including conventional endoscopic
3Rectal Neuroendocrine Tumorsmucosal resection (EMR) or EMR with precutting (EMR-
P), EMR with a ligation device (EMR-L) and endoscopic
submucosal (SM) dissection with or without snaring
(ESD-S or ESD) [13]. ER was performed using a single-
channel colonoscope. Conventional EMR was performed by snare poly-
pectomy with a blended electrosurgical currentTable 1 Demographic and clinical features of patients w
Total number of patients, n (tumors, n)
Age, median (range), years
Sex
Male
Female
Size of rectal neuroendocrine tumor, mean 7SD (mm)
Distance from anal verge, mean (cm)
Treatment, n
Endoscopic resection
Surgical resection
Chemotherapy
SD, standard deviation.
Table 2 Predictive factors of metastasis on univariate a
Total (n=468) Metastasis (n
LN (n=21)
Size
o10 mm 368 (78.6%) 3 (0.8%)
Z10 mm 100 (21.4%) 18 (18.0%)
Color
Yellowish 413 (88.2%) 6 (1.5%)
Hyperemic 55 (11.8%) 15 (27.3%)
Shape
Sessile 313 (66.9%) 5 (1.6%)
Polypoid 155 (33.1%) 16 (10.3%)
Contour
Regular 385 (82.3%) 7 (1.8%)
Irregular 83 (17.7%) 14 (16.9%)
Surface change
Smooth 411 (87.8%) 9 (2.2%)
Depression or erosion 41 (8.8%) 0 (0%)
Ulceration 16 (3.4%) 12 (75.0%)after SM injection of a hypertonic saline solution
mixed with a small amount of indigo-carmine and
diluted epinephrine (1:10,000). EMR-P was per-
formed by snare polypectomy after circumferential
mucosal incision using a needle knife or hook knife. EMR-L was performed by snare polypectomy with
an attached single-band ligator. Snare polypectomyith rectal neuroendocrine tumors.
468 (468)
49.0 (19–80)
308 (65.8%)
160 (34.2%)
7.375.67 (range, 1–80)
7.4 (range, 2–18)
369
91
8
nalysis.
=21) P value
Distant (n=11) Total (n=21)
0.000
1 (0.3%) 3 (0.8%)
10 (10.0%) 18 (18.0%)
0.000
2 (0.5%) 6 (1.5%)
9 (16.4%) 15 (27.3%)
0.000
2 (0.6%) 5 (1.6%)
9 (5.8%) 16 (10.3%)
0.000
1 (0.3%) 7 (1.8%)
10 (12.0%) 14 (16.9%)
0.000
2 (0.5%) 9 (2.2%)
0 (0%) 0 (0%)
9 (56.2%) 12 (75.0%)
Table 3 Predictive factors for metastasis on multivariate analysis.
Odds ratio (95% CI) P value
Size (Z10 mm) 5.920 (1.204–29.107) 0.029
Hyperemic change 4.837 (1.315–17.790) 0.018
Polypoid lesion 1.126 (0.261–4.856) 0.874
Irregular contour 2.388 (0.634–8.990) 0.198
Surface ulceration 10.825 (2.091–56.033) 0.005
Table 4 The risk of metastasis by number of predictive factors.
Number of
risk factors
Odds ratio (95% CI) P value
0 1
1 5.897 (0.970–35.837) 0.054
2 73.286 (13.561–396.054) 0.000
3 427.500 (69.955–2612.485) 0.000
Risk factors: Z10 mm, hyperemic change, surface ulceration.
Table 5 The risk stratiﬁcation of metastasis by endoscopic features.
Stratiﬁcation
of risk factors
Odds ratio
(95% CI)
P value
o10 mm, No hyperemic change, no ulceration 1
o10 mm
With hyperemic
change or ulceration
7.435 (0.650–85.070) 0.107
Z10 mm 5.344 (0.739–38.628) 0.097
With hyperemic
change or ulceration
73.286 (13.561–396.054) 0.000
With both hyperemic
change and ulceration
427.500
(69.955–2612.485)
0.000
E.R. Kim et al.4was performed below the band using a blended
electrosurgical current after SM injection of a
hypertonic saline solution mixed with a small
amount of indigo-carmine and diluted epinephrine
(1:10,000). ESD was performed using a needle knife or hook
knife with an electrosurgical unit after SM
injection. A mixture of 10% glycerin, 5% fruc-
tose, and 0.9% saline was used as the SM injec-
tion solution. After lifting the tumor, a mucosal
incision and SM dissection was made with a
needle knife or ﬂex knife. ESD-S involved initi-
ally performing ESD and then using snaring for
the ﬁnal resection step. SM dissection pro-
gressed circumferentially only to the degreethat the undissected SM tissue was about 1 cm or
less in diameter. The attached, narrowed SM
tissue was then snared and resected using an
electric current.
6. Statistical analysis For the analysis of risk factors for metastasis,
the relationship between each clinicopathologi-
cal variable and the presence of metastasis was
evaluated using univariable and multivariable
logistic models. P values of o0.05 were considered statistically
signiﬁcant.
5Rectal Neuroendocrine Tumors7. Results The mean age at diagnosis was 49 years (range, 19–
80 years) and 65.8% of patients were male. Rectal
NETs were located a mean of 7.4 cm (range, 2–
18 cm) from the anal verge and measured a mean
7.375.67 mm in maximal diameter. A total of 369
patients were treated with endoscopic resection
and 91patients (10 of whom underwent surgery
after initial endoscopic resection) were treated
with surgery (Table 1). Twenty-one of the 468 patients (4.5%) with rectal
NETs had LN metastasis and 11 patients (2.4%) had
distant metastasis, mainly in the liver. Risk factors
for metastasis identiﬁed by univariate analysis
included tumor size (Z10 mm in diameter),
hyperemic change, polypoid lesions, irregular con-
tours, and surface ulceration (Table 2). Indepen-
dent factors that were predictive of metastasis on
multivariate analysis included tumor size
(Z10 mm in diameter), hyperemic change, and
surface ulceration (Table 3). None of the 244 patients (52.1%) with rectal NETs
that satisﬁed ﬁve endoscopic morphology of
o10 mm in diameter, no hyperemic change, sessile
lesions, regular contours, and smooth surface, had
metastasis. As the number of independent risk
factor for metastasis increased, the risk of metas-
tasis also rose (Table 4). The risk of metastasis was stratiﬁed according to
tumor size and morphologic predictive factors
(Table 5). The larger the tumor size and the more
morphologic predictive factors appeared, the more
the risk of metastasis increased. The presence of
endoscopic features such as hyperemic change and
surface ulceration was important as a part of initial
risk stratiﬁcation for metastasis, along with
tumor size.
8. Discussion
The results of the present study were consistent with
those of earlier studies that reported that tumor size is
an indicator of metastasis [7,8,14]. However, in our
study, three of the 368 patients with rectal NETs
o10 mm had LN metastasis. Among them, one patient
even presented with multiple hepatic metastasis. This
study showed that in addition to tumor size, general
shape, color, contour, and surface changes of tumors on
endoscopic observation also correlate with regional LN
or distant metastasis. In particular, hyperemic change
and the surface ulceration of tumors with tumor sizewere excellent predictors of metastasis. Moreover, as
the number of predictive factors for metastasis including
Z10 mm in diameter, hyperemic changes and surface
ulceration of tumors increased, the risk of metastasis
also rose.
Previous studies have focused on histopathologic fea-
tures such as depth of invasion, lymphovascular invasion,
histologic differentiation, and mitosis to predict metas-
tasis or outcomes. However, these histopathologic fea-
tures have a limited role to play in determining a
treatment plan because they are difﬁcult to assess
before surgery or endoscopic resection. Few studies have
reported characteristic endoscopic features that corre-
late with metastasis in rectal NETs. Shim et al. [15]
reported 15 rectal carcinoid tumor patients with atypical
endoscopic appearance. However they could not demon-
strate the prognostic value of atypical endoscopic
appearance because they focused on the rate of correct
endoscopic diagnosis and the sample size was too small
[15]. They suggested only that ulceration may be a useful
prognostic factor because invasion into the muscularis
propria or metastasis was signiﬁcantly more common in
cases with tumor ulceration (three of the four patients
whose tumors showed ulceration). Recently, Kim et al.
demonstrated the relationship between endoscopic fea-
tures and metastasis in rectal NETs. They showed that
atypical endoscopic features including tumor shape,
surface change and color were correlated with metas-
tasis in rectal NETs [12]. However, in their study, 9 out of
9 patients with tumors Z20 mm in diameter and none of
93 patients with tumors o10 mm in diameter presented
with metastasis. Therefore, they insisted that primary
tumor size is the best parameter for predicting the
behavior of rectal NETs measuring o10 or Z20 mm in
diameter and they focused on tumors 10–19 mm in
diameter. Of the atypical endoscopic features, only
atypical surface change exhibited an association with
metastasis in rectal NETs 10–19 mm in diameter. In
contrast, in the present study, three of 368 patients with
rectal carcinoid tumor o10 mm in diameter presented
with metastasis. Therefore, primary tumor size alone is
insufﬁcient when it comes to predicting the behavior of
rectal NETs. Hence we classiﬁed all rectal carcinoid
tumors according to endoscopic features such as color,
shape, contour, and surface change. These endoscopic
features were correlated with the presence of metasta-
sis, and atypical endoscopic features such as hyperemic
change, polypoid lesions, irregular contours, and surface
ulceration occurred more frequently as the size of the
tumor increased (35.6% in tumors o10 mm in diameter,
82.6% in tumors 10–19 mm in diameter and 100% in
tumors Z20 mm in diameter, p=0.000). However, none
E.R. Kim et al.6of these endoscopic features alone completely predicted
the presence of metastasis. On the other hand, it was
noteworthy that none of patients with rectal NETs that
satisﬁed all of ﬁve endoscopic morphology ofo10 mm in
diameter, no hyperemic change, sessile lesions, regular
contours, and smooth surface, had metastasis. Thus, we
tried to combine these endoscopic features into a risk
assessment of metastasis for rectal NETs. As expected, as
the number of predictive factors for metastasis
increased, the risk of metastasis also rose.
Based on these results, we determined the risk
stratiﬁcation of metastasis. Even though it was not
statistically signiﬁcant, the risk of metastasis was
higher in rectal NETs o10 mm in diameter with
atypical endoscopic features than in rectal carcinoid
tumor o10 mm in diameter without atypical endo-
scopic features (odd ratio, 7.435 vs. 1, p=0.107). In
rectal NETs Z10 mm in diameter, the risk of metas-
tasis increased as the number of the number of
predictive factors for metastasis increased (odd ratio,
5.344 vs. 73.286 vs. 427.500, p=0.097 vs. 0.000 vs.
0.000, Table 5).
The current study was a retrospective single
center study. The sample size in the metastasis group
was small. However, compared with previous studies
and considering the rate of metastasis of rectal
carcinoid tumors, the sample size was not insufﬁ-
cient. The present study is meaningful in that we
focused on morphologic parameters and stratiﬁed
these features in detail, according to the risk of
metastasis. Although the total sample size of our
study was not insufﬁcient, to establish this risk
stratiﬁcation using endoscopic features, further pro-
spective and large scale studies are needed.
In conclusion, this study suggested that endoscopic
features such as hyperemic change, polypoid lesions,
irregular contours, and surface ulcers with a tumor size
Z10 mm in diameter are associated with regional LN or
distant metastasis of rectal NETs. In particular, atypical
endoscopic features including hyperemic change, and
surface ulcers with a tumor size Z10 mm in diameter
may help predict the risk of metastasis of rectal NETs and
may assist in determining treatment plans for these
rectal NETs preoperatively.8.1. Take-home messages In addition to tumor size, the shape, color, con-
tour, and surface change of tumor are correlated
with metastasis of rectal neuroendocrine tumors
(NETs). Hyperemic change and surface ulceration with a
tumor size Z10 mm in diameter are excellent
parameters predicting metastasis. The risk stratiﬁcation combining these endoscopic
features with tumor size may help in determining
treatment plans for rectal NETs preoperatively.
9. Scripted voiceoverVoiceover Text
The incidence of the rectal neuroendocrine tumors
has increased. The histologic features of rectal
neuroendocrine tumors have a limited role to play
in determining treatment plan.
Between January 2000 and May 2011, the medical
records of 468 patients with rectal neuroendocrine
tumors were analyzed. All tumors were classiﬁed
according to size and endoscopic features. The
study aimed to investigate the morphologic
parameters associated with metastasis, and to
assess the risk of metastasis.
It is reported that rectal neuroendocrine tumors
smaller than 10mm rarely metastasize. However, in
this case, despite of small size of rectal tumor being
only 6mm, the patient presented with multiple
hepatic metastasis. Therefore, it is insufﬁcient to
predict the behavior of rectal neuroendocrine
tumors by primary tumor size alone.
Generally, rectal neuroendocrine tumors appear as
smooth, yellowish and round sessile lesion.
Tumor size is one of the most important risk factor. In
our study, tumor size is less than 10mm in 78.6%.
Also, we classiﬁed all rectal neuroendocrine tumors
according to endoscopic features: color, shape,
contour, and surface changes. In our study, 88% of
rectal tumors have yellowish color, 12% show
hyperemic changes, ...
... 67% appear sessile, 33% are polypoid, ...
... 82% of these tumors have regular contour.
The surface changes are classiﬁed under smooth
(88%), depression or erosion (8.8%), and ulceration
(3.4%).
This study show that in addition to tumor size, general
shape, color, contour, and surface changes of tumor
were correlated with regional lymph node or distant
metastasis. On multivariate analysis, hyperemic
change and surface ulceration of tumors with tumor
size are excellent parameters predicting
metastasis.
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Furthermore, this table show that as the number of
independent predictive factors for metastasis
increased, the risk of metastasis also rose.
The risk of metastasis is stratiﬁed according to tumor
size and predictive morphologic parameters. The
larger the tumor size and more morphologic
predictive factors appeared, the more the risk of
metastasis increased.
This is a 34-year-old female patient referred for
rectal neuroendocrine tumor. There is a smooth
yellowish submucosal tumor, it is small and show
typical morphologic ﬁnding of rectal
neuroendocrine tumor. It can be easily managed
with endoscopic treatment.
After submucosal injection, the mucosa around the
neuroendocrine tumor is incised by needle knife.
The lifted submucosal tissue beneath the lesion is
dissected from the muscle layer. The attached,
narrowed submucosal tissue is then snared and
resected by using an electric current.
This is another rectal neuroendocrine tumor. This is a
30-year-old male patient. The tumor shows the
depression on the surface. Even though the tumor
size was smaller than 10 mm, we performed CT
scan before endoscopic treatment. After
conﬁrmation of non-metastatic disease, we
performed endoscopic resection. When endoscopic
resection is done, it is important that the deep
resection margin be as close to the proper muscle
as possible.
Endosopic submucosal dissection are provided a
higher pathologic complete resection rate
compared with endoscoic mucosa resection. Now,
tumor is resected by snaring after submucosal
dissection. Endoscopic submuocsal dissection is
technically difﬁcult and requires highly skilled
endoscopists.
The recent studies reported that both the en bloc
resection rate and the histologically complete
resection rate for the lesions of o20 mm were not
different for ESD vs. ESD with snaring. Therefore,
ESD with snaring can be a good alternative to ESD
for en bloc resection of rectal neuroendocrine
tumors.
As a result, risk factors for metastasis include tumor
size, hyperemic change, polypoid lesion, irregular
contour, and surface ulceration. Independent risk
factors for metastasis include tumor size, hypermic
change, and surface ulceration. As the number of
independent risk factor for metastasis increased,
the risk of metastasis also rose.Voiceover Text
To sum up, in addition to tumor size, the shape,
color, contour, and surface change of tumors are
correlated with metastasis of rectal
neuroendocrine tumors. Hyperemic change and
surface ulceration with a tumor size are excellent
parameters predicting metastasis. The risk
stratiﬁcation combining these endoscopic features
with tumor size may help in determining treatment
plans for rectal neuroendocrine tumors
preoperatively.Funding source
None.
Conﬂict of interest
None.
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